Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMCOpen access

NADPH Oxidases: Insights into Selected Functions and Mechanisms of Action in Cancer and Stem Cells

Skonieczna M., Hejmo T., Poterala-Hejmo A., Cieslar-Pobuda A., Buldak RJ.

Narrative Review, published in Oxid Med Cell Longev (2017) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
Oxid Med Cell Longev (2017)
Reported sample size
—
Source database
Europe PMC
PMID
28626501
PMCID
PMC5463201
DOI
10.1155/2017/9420539
Citations
102

Abstract (original English)

NADPH oxidases (NOX) are reactive oxygen species- (ROS-) generating enzymes regulating numerous redox-dependent signaling pathways. NOX are important regulators of cell differentiation, growth, and proliferation and of mechanisms, important for a wide range of processes from embryonic development, through tissue regeneration to the development and spread of cancer. In this review, we discuss the roles of NOX and NOX-derived ROS in the functioning of stem cells and cancer stem cells and in selected aspects of cancer cell physiology. Understanding the functions and complex activities of NOX is important for the application of stem cells in tissue engineering, regenerative medicine, and development of new therapies toward invasive forms of cancers.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
HumansNeoplasmsReactive Oxygen SpeciesCell DifferentiationNADPH Oxidases

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.